Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

World Journal of Biological Psychiatry

Volumn 15, Issue 3, 2014, Pages 251-258

  Chowdhury, Nabilah I ^a   Souza, Renan P ^b   Tiwari, Arun K ^a   Brandl, Eva J ^a   Sicard, Michelle ^a   Meltzer, Herbert Y ^c   Lieberman, Jeffrey A ^d   Kennedy, James L ^a,e   Müller, Daniel J ^a,e  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antipsychotics; Clozapine; Melanocortin; Olanzapine; Schizophrenia

Indexed keywords

AGOUTI RELATED PROTEIN; AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; FLUPHENAZINE; HALOPERIDOL; MELANOCORTIN; NEUROLEPTIC AGENT; OLANZAPINE; POLYPEPTIDE; PROOPIOMELANOCORTIN; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; BODY WEIGHT DISORDER; CELL POPULATION; CONTROLLED STUDY; ENERGY; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; MAJOR CLINICAL STUDY; MALE; NERVE CELL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT CHANGE; WEIGHT CONTROL; WEIGHT GAIN;

ADULT; AGOUTI-RELATED PROTEIN; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRO-OPIOMELANOCORTIN; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

EID: 84896745733     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.858827     Document Type: Article

References (45)

1. Argyropoulos G, Rankinen T, Neufeld DR, Rice T, Province MA, Leon AS, et al. 2002. A polymorphism in the human agoutirelated protein is associated with late-onset obesity. J Clin Endocrinol Metab 87: 4198-4202.
2. Baker M, Gaukrodger N, Mayosi BM, Imrie H, Farrall M, Watkins H, et al. 2005. Association between common polymorphisms of the proopiomelanocortin gene and body fat distribution: a family study. Diabetes 54: 2492-2496. (Pubitemid 41134281)
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
4. Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL. 2002. 759C/T genetic variation of 5HT(2C) receptor and clozapineinduced weight gain. Lancet 360: 1790-1791. (Pubitemid 35447927)
5. Beasley CM Jr, Tollefson GD, Tran PV. 1997. Safety of olanzapine. J Clin Psychiatry 58(Suppl 10): 13-17. (Pubitemid 27333175)
6. Beaudry G, Zekki H, Rouillard C, Levesque D. 2004. Clozapine and dopamine D3 receptor antisense reduce cocaine-and amphetamine-regulated transcript expression in the rat nucleus accumbens shell. Synapse 51: 233-240. (Pubitemid 38140896)
7. Bienertova-Vasku JA, Spinarova L, Bienert P, Vasku A. 2009. Association between variants in the genes for leptin, leptin receptor, and proopiomelanocortin with chronic heart failure in the Czech population. Heart Vessels 24: 131-137.
8. Bonilla C, Panguluri RK, Taliaferro-Smith L, Argyropoulos G, Chen G, Adeyemo AA, et al. 2006. Agouti-related protein promoter variant associated with leanness and decreased risk for diabetes in West Africans. Int J Obes (London) 30: 715-721.
9. Brady LS, Smith MA, Gold PW, Herkenham M. 1990. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52: 441-447. (Pubitemid 20366597)
10. Brandl EJ, Frydrychowicz C, Tiwari AK, Lett TA, Kitzrow W, Büttner S, et al. 2012. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog Neuropsychopharmacol Biol Psychiatry 38: 134-141.
11. Cheung WW, Mao P. 2012. Recent advances in obesity: genetics and beyond. ISRN Endocrinol 2012: 536905.
12. Chowdhury NI, Tiwari AK, Souza RP, Zai CC, Shaikh SA, Chen S, et al. 2013. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene. Pharmacogenomics J 13: 272-279.
13. Cone RD. 2005. Anatomy and regulation of the central melanocortin system. Review. Nat Neurosci 8: 571-578. (Pubitemid 40594196)
14. del Giudice EM, Santoro N, Cirillo G, D ' Urso L, Di Toro R, Perrone L. 2001. Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 50: 2157-2160. (Pubitemid 33643685)
15. Davoodi N, Kalinichev M, Korneev SA, Clifton PG. 2009.Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine. Psychopharmacology (Berlin) 203: 693-702.
16. Echwald SM, Sorensen TI, Andersen T, Hansen C, Tommerup N, Pedersen O. 1999. Sequence variants in the human cocaine and amphetamine-regulated transcript (CART) gene in subjects with early onset obesity. Obes Res 7: 532-536. (Pubitemid 129710617)
17. Ferno J, Varela L, Skrede S, Vazquez MJ, Nogueiras R, Dieguez C, et al. 2011. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One 6: e20571.
18. Fu M, Cheng H, Chen L, Wu B, Cai M, Xie D, et al. 2002. Association of the cocaine and amphetamine-regulated transcript gene with type 2 diabetes mellitus. Zhonghua Nei Ke Za Zhi 41: 805-808.
19. Gaudermann P, Vogl I, Zientz E, Silva FJ, Moya A, Gross R, et al. 2006. Analysis of and function predictions for previously conserved hypothetical or putative proteins in Blochmannia fl oridanus. BMC Microbiol 6: 1.
20. Gebhardt S, Theisen FM, Haberhausen M, Heinzel-Gutenbrunner M, Wehmeier PM, Krieg JC, et al. 2010. Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study. J Clin Pharm Ther 35: 207-211.
21. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. 1997. verexpression of Agrt leads to obesity in transgenic mice. Nat Genet 17: 273-274.
22. Haskell-Luevano C, Monck EK. 2001. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 99: 1-7. (Pubitemid 32232121)
23. Lahiri DK, Nurnberger JI Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19: 5444.
24. Lee SJ, Verma S, Simonds SE, Kirigiti MA, Kievit P, Lindsley SR, et al. 2013. Leptin stimulates neuropeptide Y and cocaine amphetamine-regulated transcript coexpressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice. J Neurosci 33: 15306-15317.
25. Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ. 2012. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 17: 242-266.
26. Lencz T, Malhotra AK. 2009. Pharmacogenetics of antipsychoticinduced side effects. Review. Dialogues Clin Neurosci 11: 405-415.
27. Malhotra AK, Correll CU, Chowdhury NI, Müller DJ, Gregersen PK, Lee AT, et al. 2012. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch Gen Psychiatry 69: 904-912.
28. Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, et al. (1998). Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19: 123-132. (Pubitemid 28288438)
29. Michaud EJ, Mynatt RL, Miltenberger RJ, Klebig ML, Wilkinson JE, Zemel MB, et al. 1997. Role of the agouti gene in obesity. J Endocrinol 155: 207-209. (Pubitemid 27475810)
30. Muller DJ, De Luca V, Sicard T, King N, Hwang R, Volavka J, et al. 2005. Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. Eur Neuropsychopharmacol 15: 525-531. (Pubitemid 41219624)
31. Nasrallah HA. 2008. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profi les. Mol Psychiatry 13: 27-35. (Pubitemid 350275185)
32. Nijenhuis WA, Oosterom J, Adan RA. 2001. AgRP(83-132) acts as an inverse agonist on the human melanocortin-4 receptor. Mol Endocrinol 15: 164-171. (Pubitemid 32156049)
33. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, et al. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138. (Pubitemid 27446294)
34. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. 2009. Atypical antipsychotic drugs and the risk of sudden cardiac death. New Engl J Med 360: 225-235.
35. Rigoli L, Munafo C, Di Bella C, Salpietro A, Procopio V, Salpietro C. 2010. Molecular analysis of the CART gene in overweight and obese Italian children using family-based association methods. Acta Paediatr 99: 722-726.
36. Santini F, Maffei M, Pelosini C, Salvetti G, Scartabelli G, Pinchera A. 2009. Melanocortin-4 receptor mutations in obesity. Adv Clin Chem 48: 95-109.
37. Savontaus E, Conwell IM, Wardlaw SL. 2002. Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res 958: 130-138. (Pubitemid 35441220)
38. Sutton BS, Langefeld CD, Williams AH, Norris JM, Saad MF, Haffner SM, et al. 2005. Association of proopiomelanocortin gene polymorphisms with obesity in the IRAS family study. Obes Res 13: 1491-1498.
39. Ternouth A, Brandys MK, van der Schouw YT, Hendriks J, Jansson JO, Collier D, et al. 2011. Association study of POMC variants with body composition measures and nutrient choice. Eur J Pharmacol 660: 220-225.
40. Tiwari AK, Zai CC, Likhodi O, Lisker A, Singh D, Souza RP, et al. 2010. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychoticinduced weight gain in Schizophrenia. Neuropsychopharmacology 35: 1315-1324.
41. Tiwari AK, Brandl EJ, Weber C, Likhodi O, Zai CC, Hahn MK, et al. 2013. Association of a functional polymorphism in neuropeptide y with antipsychotic-induced weight gain in schizophrenia patients. J Clin Psychopharmacol 33: 11-17.
42. Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, et al. 2002. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 159: 255-262. (Pubitemid 34126903)
43. Walder K, Morris C, Ravussin E. 2000. A polymorphism in the gene encoding CART is not associated with obesity in Pima Indians. Int J Obes Relat Metab Disord 24: 520-521. (Pubitemid 30198108)
44. Wehmeier PM, Gebhardt S, Schmidtke J, Remschmidt H, Hebebrand J, Theisen FM. 2005. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Psychiatry Res 133: 273-276. (Pubitemid 40312160)
45. Ziotopoulou M, Erani DM, Hileman SM, Bjorbaek C, Mantzoros CS. 2000. Unlike leptin, ciliary neurotrophic factor does not reverse the starvation-induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling . Diabetes 49: 1890-1896.